Biohaven Pharmaceuticals

5 followers


Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Headquarters

Stage

Employees

Links

Org chart

Vlad Coric
CEO & Chairman

Vlad Coric

Collapse
Warren Volles
General Counsel & Chief Legal Officer
George Clark
VP, Chief Accounting Officer
Robert Croop
Chief Development Officer, Neurology
Bruce D. Car
Chief Scientific Officer
Tova Gardin
Chief Translational Officer
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Matthew Buten
Chief Financial Officer
Elyse Stock
Senior Scientific Advisor
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
David Stock
VP, Biostatistics
Michael Bozik
President, Ion Channel Research & Development
Melissa Beiner
Director, R&D
Wes Kazmierski
Senior Director, Chemistry
Katy Mcgrath
Principal Scientist, In Vivo Science
David Weaver
SVP, Neuroscience & Pharmacology